vimarsana.com
Home
Live Updates
15-day Paxlovid regimen safe but adds no clear long-COVID be
15-day Paxlovid regimen safe but adds no clear long-COVID be
15-day Paxlovid regimen safe but adds no clear long-COVID benefit
A clinical trial led by Stanford Medicine researchers has found that a 15-day course of Paxlovid, an antiviral drug targeting the virus that causes
Related Keywords
Rupinder Singh ,
Pfizer ,
Stanford Medicine ,
Viral Reservoir ,
Significant Difference ,